CompoundingToday Newsletter

Newsletter Subject
Vol. 11 No. 41 Clinical Pharmaceutics and Compounding, Part VI
Vol. 11 No. 40 Clinical Pharmaceutics and Compounding, Part V
Vol. 11 No. 39 Clinical Pharmaceutics and Compounding, Part IV
Vol. 11 No. 38 Clinical Pharmaceutics and Compounding, Part III
Vol. 11 No. 37 Clinical Pharmaceutics and Compounding, Part II
Vol. 11 No. 36 Clinical Pharmaceutics, Part I
Vol. 11 No. 35 Finally! “Named Formulas” Database Available
Vol. 11 No. 34 What is Compounding Pharmacy, XV: Summary
Vol. 11 No. 33 What is Compounding Pharmacy, Part XIV: Site Presentation
Vol. 11 No. 32 What is Compounding Pharmacy, Part XIII: Public Presentation(s)
Vol. 11 No. 31 What is Compounding Pharmacy, Part XII: Integrity and Responsibility
Vol. 11 No. 30 What is Compounding Pharmacy, Part XI: Patient Oriented
Vol. 11 No. 29 What is Compounding
Pharmacy, Part X: Problem-solving
Vol. 11 No. 28 What is Compounding Pharmacy, Part IX: Cutting Edge
Vol. 11 No. 27 What is Compounding Pharmacy, Part VIII: Patient-centered
Vol. 11 No. 26 What is Compounding Pharmacy, Part VII: Education and Training of a Compounding Pharmacist
Vol. 11 No. 25 What is Compounding Pharmacy, Part VIb: Responsibilities of a Compounding Pharmacist
Vol. 11 No. 24 What is Compounding Pharmacy, Part VIa: Responsibilities of a Compounding Pharmacist
Vol. 11 No. 23 USP Web Meeting for General Chapter <800>
Vol. 11 No. 22 What is Compounding Pharmacy, Part V: Meeting Patients' Needs
Vol. 11 No. 21 What is Compounding Pharmacy, Part IV
Vol. 11 No. 20 What is Compounding Pharmacy, Part III
Vol. 11 No. 19 What is Compounding Pharmacy, Part II: Growth Factors
Vol. 11 No. 18 What is Compounding Pharmacy, Part I
Vol. 11 No. 17 USP Chapter <800> Applies to BOTH Dispensing and Compounding Pharmacies!
Vol. 11 No. 16 My Creed
Vol. 11 No. 15 Just Thinking about 503b…
Vol. 11 No. 14 New USP <800> May Have Greater Impact than USP <797>
Vol. 11 No. 13 Student Pharmacist Compounding Competition (SPCC) 2014: University of Colorado Skaggs School of Pharmacy Wins Overall
Vol. 11 No. 12 "Inordinate amounts"; What does it mean?
Vol. 11 No. 11 Difficult to Compound, Part III
Vol. 11 No. 10 Difficult to Compound, Part II
Vol. 11 No. 9 Difficult to Compound, Part I
Vol. 11 No. 8 Is Just One List Feasible? Part II
Vol. 11 No. 7 Is Just One List Feasible? Part I
Vol. 11 No. 6 Definitions
Vol. 11 No. 5 Definitions of Compounding
Vol. 11 No. 4 FDA and the Advisory Committee on Compounding
Vol. 11 No. 3 Summary Effects of H.R. 3204, Part II (503A)
Vol. 11 No. 2 Quick Summary of H.R. 3204; Part I (503B)
Vol. 11 No. 1 FDA Guidance Under 503B
Vol. 10 No. 51 FDA Guidance Under 503a
Vol. 10 No. 50 H.R. 3204 Drug Quality and Security Act
Vol. 10 No. 49 What is Section 503A?
Vol. 10 No. 48 It's "Déjà vu all over again"…but it's real!
Vol. 10 No. 47 Polypill: Something New or History Recycling?
Vol. 10 No. 46 Reflections: Lying and Politics! Truth and Trust?
Vol. 10 No. 45 Drug Shortages 2013
Vol. 10 No. 44 New Series in the International Journal of Pharmaceutical Compounding Beginning January/February 2014!
Vol. 10 No. 43 Follow-up on Augmented Reality for Readers and Authors
Vol. 10 No. 42 New Experience at IJPC: A First in Pharmacy Publishing!
Vol. 10 No. 41 Changing Priorities
Vol. 10 No. 40 Student Pharmacist Compounding Competition
Vol. 10 No. 39 Disinfectants, Part I
Vol. 10 No. 38 United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing
Vol. 10 No. 37 Assigning Extended Beyond-Use-Dates
Vol. 10 No. 36 Three Default Beyond-use Dates in United States Pharmacopeia Chapters <795> and <797>
Vol. 10 No. 35 Sterility Testing
Vol. 10 No. 34 Depyrogenation Methods
Vol. 10 No. 33 The price of a life and pharmacy education?
Vol. 10 No. 32 How Things Change! A Follow up.
Vol. 10 No. 31 How things change!
Vol. 10 No. 30 Documentation vs Opinion on Compounding Regulatory Activities XII
Vol. 10 No. 29 Documentation vs Opinion on Compounding Regulatory Activities XI
Vol. 10 No. 28 Documentation vs Opinion on Compounding Regulatory Activities X
Vol. 10 No. 27 Documentation vs Opinion on Compounding Regulatory Activities IX
Vol. 10 No. 26 Documentation vs Opinion on Compounding Regulatory Activities VIII
Vol. 10 No. 25 Documentation vs Opinion on Compounding Regulatory Activities VII
Vol. 10 No. 24 Documentation vs Opinion on Compounding Regulatory Activities VI
Vol. 10 No. 23 Documentation vs Opinion on Compounding Regulatory Activities V
Vol. 10 No. 22 New Addition to CompoundingToday.com
Vol. 10 No. 21 Documentation vs Opinion on Compounding Regulatory Activities IV
Vol. 10 No. 20 Documentation vs Opinion on Compounding Regulatory Activities III
Vol. 10 No. 19 Documentation vs Opinion on Compounding Regulatory Activities II
Vol. 10 No. 18 Documentation vs Opinion on Compounding Regulatory Activities I
Vol. 10 No. 17 Current Good Manufacturing Practice (cGMP) Regulations, Part 13
Vol. 10 No. 16 Current Good Manufacturing Practice (cGMP) Regulations, Part 12
Vol. 10 No. 15 Current Good Manufacturing Practice (cGMP) Regulations, Part 11
Vol. 10 No. 14 Current Good Manufacturing Practice (cGMP) Regulations, Part 10
Vol. 10 No. 13 Current Good Manufacturing Practice (cGMP) Regulations, Part 9
Vol. 10 No. 12 Current Good Manufacturing Practice (cGMP) Regulations, Part 8
Vol. 10 No. 11 Current Good Manufacturing Practice (cGMP) Regulations, Part 7
Vol. 10 No. 10 Current Good Manufacturing Practice (cGMP) Regulations, Part 6
Vol. 10 No. 9 Differentiating "Manufacturing" from "Compounding"!
Vol. 10 No. 8 Current Good Manufacturing Practice (cGMP) Regulations, Part 5
Vol. 10 No. 7 It Just Doesn't Fit!
Vol. 10 No. 6 Current Good Manufacturing Practice (cGMP) Regulations, Part 4
Vol. 10 No. 5 Current Good Manufacturing Practice (cGMP) Regulations, Part 3
Vol. 10 No. 4 Current Good Manufacturing Practice (cGMP) Regulations, Part 2
Vol. 10 No. 3 Current Good Manufacturing Practice (cGMP) Regulations, Part 1
Vol. 10 No. 2 Medication Use in the United States in 2011
Vol. 10 No. 1 Another Year at the International Journal of Pharmaceutical Compounding
Vol. 9 No. 50 Repackaging Sterile and Nonsterile Products-Some Tidbits
Vol. 9 No. 49 Repackaging Nonsterile Products - Part 3
Vol. 9 No. 48 Repackaging Nonsterile Products - Part 2
Vol. 9 No. 47 Repackaging Nonsterile Products
Vol. 9 No. 46 Repackaging Sterile Products-Another Scenario
Vol. 9 No. 45 Repackaging Sterile Products
Vol. 9 No. 44 To Verify or to Validate…that is the Question!
Vol. 9 No. 43 Misrepresentations by the Press
Vol. 9 No. 42 Are Our Pharmacy Leaders Missing an Opportunity?
Vol. 9 No. 41 Compounding Pharmacists…Thank you!
Vol. 9 No. 40 Another Tragic Situation!
Vol. 9 No. 39 IJPC Achieves Another Milestone: MEDLINE
Vol. 9 No. 38 CE Record-keeping Options: Look at the Details!
Vol. 9 No. 37 "Bioidentical" Drugs are Written by ALL Prescribers!
Vol. 9 No. 36 Political Conventions: Time for a change?
Vol. 9 No. 35 It’s Football Time Again!
Vol. 9 No. 34 Defining "Politics"
Vol. 9 No. 33 Reimbursement Discrimination
Vol. 9 No. 32 Supporting Each Other
Vol. 9 No. 31 Pharmacy and the Olympics
Vol. 9 No. 29 Where did it come from and how good is it?
Vol. 9 No. 28 Liar, Liar, Pants on Fire!
Vol. 9 No. 30 The "Dog Days" of Summer
Vol. 9 No. 27 It’s time to help colleges refocus their curriculum!
Vol. 9 No. 26 CMS Clarifies Position on Single-Dose Vials
Vol. 9 No. 25 Those Difficult Professors…Friend or Fiend?
Vol. 9 No. 24 Pharmacy Students Compounding Sterile Preparations in Experiential Practice Sites
Vol. 9 No. 23 The Idea Light Bulb!
Vol. 9 No. 22 United States Pharmacopeia 101, Part X
Vol. 9 No. 21 United States Pharmacopeia 101, Part IX
Vol. 9 No. 20 United States Pharmacopeia 101, Part VIII
Vol. 9 No. 19 United States Pharmacopeia 101, Part VII
Vol. 9 No. 18 United States Pharmacopeia 101, Part VI
Vol. 9 No. 17 United States Pharmacopeia 101, Part V
Vol. 9 No. 16 United States Pharmacopeia 101, Part IV
Vol. 9 No. 15 United States Pharmacopeia 101, Part III
Vol. 9 No. 14 United States Pharmacopeia 101, Part II
Vol. 9 No. 13 United States Pharmacopeia 101, Part I
Vol. 9 No. 12 University of Oklahoma College of Pharmacy-Tulsa Campus Wins First Place at 2012 National Student Compounding Competition
Vol. 9 No. 11 Blowin' in the Wind…
Vol. 9 No. 10 Learning requires effort and work!
Vol. 9 No. 9 Smidgen, pinch, dash, tad, drop, and hint
Vol. 9 No. 8 Looking Forward 2012, Part VII: DEA Harming Patients
Vol. 9 No. 6 Looking Forward 2012, Part V
Vol. 9 No. 7 Looking Forward 2012, Part VI-Service Pays Off!
Vol. 9 No. 5 Looking Forward 2012, Part IV
Vol. 9 No. 4 Looking Forward 2012, Part III
Vol. 9 No. 3 Looking Forward 2012, Part II
Vol. 9 No. 2 Looking Forward 2012, Part I
Vol. 9 No. 1 Suggestions for the Political Process
Vol. 8 No. 51 Welcome 2012-Are You Better Off?
Vol. 8 No. 50 "A great present for U.S. taxpayers for 2011"?
Vol. 8 No. 49 Faith, Fact, and Fantasy
Vol. 8 No. 48 ASHP Clinical Midyear Lacks Compounding Programming
Vol. 8 No. 47 Just Wondering, Where Does All the Money Go?
Vol. 8 No. 46 NIH Pediatric Formulations Seminar
Vol. 8 No. 45 More on the United States Pharmacopeia General Notices, Part X
Vol. 8 No. 44 More on the United States Pharmacopeia General Notices, Part IX
Vol. 8 No. 43 More on the United States Pharmacopeia General Notices, Part VIII
Vol. 8 No. 42 More on the United States Pharmacopeia General Notices, Part VI
Vol. 8 No. 41 More on the United States Pharmacopeia General Notices, Part VI
Vol. 8 No. 40 More on the United States Pharmacopeia General Notices, Part V
Vol. 8 No. 39 More on the United States Pharmacopeia General Notices, Part IV
Vol. 8 No. 38 More on the United States Pharmacopeia General Notices, Part III
Vol. 8 NO. 37 Court Decision Supports Compounding
Vol. 8 No. 36 More on the United States Pharmacopeia General Notices, Part II
Vol. 8 No. 35 More on the United States Pharmacopeia General Notices, Part I
Vol. 8 No. 34 What is "about" all about?
Vol. 8 No. 33 USP Salt and Base Nomenclature, Part 2
Vol. 8 No. 32 Salt and Base Nomenclature
Vol. 8 No. 31 Principles, Values, and Compromise
Vol. 8 No. 30 Jumping into New Markets!
Vol. 8 No. 29 Deceptive Practices
Vol. 8 No. 28 Fact vs Opinion
Vol. 8 No. 27 Lies and Lying!
Vol. 8 No. 26 Freedom Only Works with Responsibility
Vol. 8 No. 25 "The Priceless Ingredient"
Vol. 8 No. 24 IACP CCH 2011 - A Great Meeting
Vol. 8 No. 23 Johnny Cash and the National Debt
Vol. 8 No. 22 Disappointment, Disillusionment, Disgust!
Vol. 8 No. 21 Fraidy Holes
Vol. 8 No. 20 Keeping up with Science and Technology!
Vol. 8 No. 19 Commercials or Programs?
Vol. 8 No. 18 Pharmacists and Retirement
Vol. 8 No. 17 Expiration Dates, Drug Waste and Pollution
Vol. 8 No. 16 Data Related to the Extent of Compounding
Vol. 8 No. 15 Three National Pharmacy Meetings in Three Weeks
Vol. 8 No. 14 “Do it right!” vs “Just do it!”
Vol. 8 No. 13 17P, Makena and Compounding: Not an April Fools Joke!
Vol. 8 No. 12 Insurance Plans Support Hydroxyprogesterone Caproate Compounding
Vol. 8 No. 11 If it ain't broke, don't fix it!
Vol. 8 No. 10 I’m on my way!
Vol. 8 No. 9 Does a "Limited Distribution System" fit the definition of "Commercially Available"?
Vol. 8 No. 8 What happened?
Vol. 8 No. 7 What Do You Sell?
Vol. 8 No. 6 Affiliation Agreement Reached between IJPC and IACP
Vol. 8 No. 5 Discontinued Drugs
Vol. 8 No. 4 Drug Shortages
Vol. 8 No. 3 Two Inter-related Stories
Vol. 8 No. 2 Small but Powerful! Auxiliary Labels
Vol. 8 No. 1 "...but the fact of the matter is…"
Vol. 7 No. 52 Crossroads or Crosshairs?
Vol. 7 No. 51 Take Time...
Vol. 7 No. 50 Changes in Compounders' Network List
Vol. 7 No. 49 ASHP 2010
Vol. 7 No. 48 Sense, Common Sense, Horse Sense: Are We Using It?
Vol. 7 No. 47 Thanksgiving
Vol. 7 No. 46 Changes and Opportunities
Vol. 7 No. 45 Travel Tips: It's That Time of the Year
Vol. 7 No. 44 Musings on the "V-O-T-E"
Vol. 7 No. 43 Informative Response from Greece
Vol. 7 No. 42 What others are teaching our children!
Vol. 7 No. 41 Isn't It Great!
Vol. 7 No. 40 ACA Meeting
Vol. 7 No. 39 Documentation of Potential Problems in Compounding with Manufactured Products
Vol. 7 No. 38 Possible Answers to Some Questions
Vol. 7 No. 37 Insurance Company Discrimination, Revisited-Time for a Class Action?
Vol. 7 No. 36 A Day to Celebrate the Worker!
Vol. 7 No. 35 I Remember When…The American Dream
Vol. 7 No. 34 Business Approach to Government
Vol. 7 No. 33 Thoughts about Health Professionals
Vol. 7 No. 32 Dog Days are Here
Vol. 7 No. 31 Paper or Plastic? Paper or Digital?
Vol. 7 No. 30 Are we really where we want to be?
Vol. 7 No. 29 Compounding with Hazardous Drugs
Vol. 7 No. 28 Planning!
Vol. 7 No. 27 Independence Day
Vol. 7 No. 26 Approved, Unapproved, Legal, and Illegal Drugs
Vol. 7 No. 25 Use Most Current Information
Vol. 7 No. 24 Should Pharmacy Depend Upon Governmental Programs?
Vol. 7 No. 23 Considerations in a Global Pharmaceutical System
Vol. 7 No. 22 Spring Cleaning
Vol. 7 No. 21 Graduation Time of the Year
Vol. 7 No. 20 Catch-22: FDA-CPG on Veterinary Compounding
Vol. 7 No. 19 USP Compounding Resolution 8 Information
Vol. 7 No. 18 USP Convention Follow-up
Vol. 7 No. 17 2010 USP Convention
Vol. 7 No. 16 NHIA 2010 Annual Meeting
Vol. 7 No. 15 Balance: It's Important
Vol. 7 No. 14 Higher Standards…Athletes or the U.S. Congress?
Vol. 7 No. 13 BS + Internship or PharmD (Both 6 years of training to become a licensed pharmacist)
Vol. 7 No. 12 Don’t you just love “elitism”!
Vol. 7 No. 11 Spring Forward!
Vol. 7 No. 10 Does the end justify the means?
Vol. 7 No. 9 Communications
Vol. 7 No. 8 Presidents' Day and Washington's Birthday: Which is Which?
Vol. 7 No. 7 Valentine's Day! Who/What Are We Celebrating?
Vol. 7 No. 6 Quality Improvement in Pharmaceutical Compounding
Vol. 7 No. 5 Thinking About Tomorrow!
Vol. 7 No. 4 Working Together
Vol. 7 No. 3 Confusing Rules with Principles
Vol. 7 No. 2 Cowboy Ethics Revisited: What Has Happened to Our Culture?
Vol. 7 No. 1 Happy New Year!
Vol. 6 No. 50 Merry Christmas!
Vol. 6 No. 49 A Profession or a Job
Vol. 6 No. 48 The U.S. Healthcare System is NOT “Broken”!
Vol. 6 No. 47 Thanksgiving
Vol. 6 No. 46 Media and Political Manipulation: Who is Manipulating Whom?
Vol. 6 No. 45 Tamiflu Suspension Revisited
Vol. 6 No. 44 Are these still in effect? Part 2
Vol. 6 No. 43 Are these still in effect? Part 1
Vol. 6 No. 42 2009 NCPA Program Sessions on Compounding in New Orleans
Vol. 6 No. 41 Thyroid and Tamiflu!
Vol. 6 No. 40 The 2009 H1N1 Flu, the Media, and the RxTriad
Vol. 6 No. 39 Aging
Vol. 6 No. 38 Melamine is Back!
Vol. 6 No. 37 Drug Product Shortages: Opportunities for Compounding
Vol. 6 No. 36 Labor Day: How it Came About; What it Means
Vol. 6 No. 35 False Economy? Think before you act!
Vol. 6 No. 34 Privacy vs Need to Know: How far do we put our trust?
Vol. 6 No. 33 Basis for decisions: Documentation and/or judgment
Vol. 6 No. 32 Snippets!
Vol. 6 No. 31 Let's make a deal!
Vol. 6 No. 30 Believe it or not!
Vol. 6 No. 29 The Age of Communications for the Ages
Vol. 6 No. 28 Florida Pharmacists Association Annual Meeting 2009
Vol. 6 No. 27 We're All In This Together!
Vol. 6 No. 26 Compounders on Capitol Hill a Great Success
Vol. 6 No. 25 Trends in Drug Shortages; Opportunities for Compounding, Part 2
Vol. 6 No. 24 Trends in Drug Shortages; Opportunities for Compounding, Part 1
Vol. 6 No. 23 Quality Assurance of Parenteral Preparations
Vol. 6 No. 22 Automatons
Vol. 6 No. 21 Wyeth is at it again! Women are being cheating of estriol and Medicaid of millions of dollars
Vol. 6 No. 20 Quality Assurance of Special Hard Gelatin Capsules
Vol. 6 No. 19 Compounding Around the World
Vol. 6 No. 18 Quality Assurance of Suppositories, Troches, Lollipops, and Sticks
Vol. 6 No. 17 Quality Control, Quality Assurance and Quality Improvement-What is the Difference and Why Should You Care?
Vol. 6 No. 16 Going backwards?
Vol. 6 No. 15 Quality Assurance of Ointments, Creams, and Gels
Vol. 6 No. 14 Quality Assurance of Oral and Topical Liquids
Vol. 6 No. 13 Quality Assurance of Powder-Filled, Hard-Gelatin Capsules
Vol. 6 No. 12 Is it realistic to think that through the government…
Vol. 6 No. 11 INFARMA 2009
Vol. 6 No. 10 Life, Liberty, and the Pursuit of Happiness OR ...
Vol. 6 No. 9 States of Matter; States of States!
Vol. 6 No. 8 Back to the Basics!
Vol. 6 No. 7 My Two Cents!
Vol. 6 No. 6 Discussion of Data and Demeanor
Vol. 6 No. 5 Insurance Discrimination! Time for a Class Action xyzxyz?
Vol. 6 No. 4 Things are Changing!
Vol. 6 No. 3 Change!
Vol. 6 No. 2 The Blind Leading the Blind; Let’s Open Their Eyes
Vol. 6 No. 1 Resolutions Anyone?
Vol. 5 No. 49 It's Hard to Believe!
Vol. 5 No. 48 Economic Correction May Be What We Need
Vol. 5 No. 47 Lack of Discipline or Circumstances: What is the Cause?
Vol. 5 No. 46 Thanksgiving
Vol. 5 No. 45 Isn't it interesting that...
Vol. 5 No. 44 A lot of "bellyaching" going on this past year!
Vol. 5 No. 43 “New Drug,” Labeling, and Label Responsibility
Vol. 5 No. 42 Stress
Vol. 5 No. 41 Should Black-Box Warnings be Dispensed with Commercial Prescriptions?
Vol. 5 No. 40 Are we there yet?
Vol. 5 No. 39 Misdirection
Vol. 5 No. 38 Compounding Around the World!
Vol. 5 No. 37 "Reporters" or "Political Activists"
Vol. 5 No. 36 8-Tracks for Sale
Vol. 5 No. 35 The Politics of Change
Vol. 5 No. 34 AMA Action on Non-FDA-Approved Compounded Medications
Vol. 5 No. 33 Dumb, Dumber, and Dumbest!
Vol. 5 No. 32 Healthcare Reform: Different Things to Different People
Vol. 5 No. 31 Cephalosporin Extra-Label Use to be Banned
Vol. 5 No. 30 Standardized Formulas
Vol. 5 No. 29 "New Drug", "Labeling" and the Midland Decision
Vol. 5 No. 28 “Compounding Around the World”
Vol. 5 No. 27 Who Owns the United States?
Vol. 5 No. 26 Two Little Words
Vol. 5 No. 25 Should the Government and Insurance Companies Pay for "Lifestyle" Drugs?
Vol. 5 No. 24 DTC Advertising!
Vol. 5 No. 23 IJPC-APhA Strategic Alliance
Vol. 5 No. 22 It's Here—USP Chapter <797> is Official
Vol. 5 No. 21 Lookin’, Learnin’, and Lobbyin’ at CCH 2008
Vol. 5 No. 20 Made in the USA
Vol. 5 No. 19 Twelve "Whereas's" and 1 "Be it Resolved"!
Vol. 5 No. 18 Have We Learned Our Lesson Yet?
Vol. 5 No. 17 USP Chapter <797> Question of the Week
Vol. 5 No. 16 USP Chapter <797> Frequently Asked Questions
Vol. 5 No. 15 No recourse for patients and consumers!
Vol. 5 No. 14 USP Chapter <797> Workshop #1
Vol. 5 No. 13 Examinations for Students on Rotations?
Vol. 5 No. 12 FDA Losing Credibility
Vol. 5 No. 11 My Drug Problem (Anonymous Submission)
Vol. 5 No. 10 Who's running the country?
Vol. 5 No. 9 Change: One of the constants of the universe!
Vol. 5 No. 8 Ethiopia Project
Vol. 5 No. 7 Double Standards
Vol. 5 No. 6 Eleven Rules of Life
Vol. 5 No. 5 Opinions and Convictions: Who are you?
Vol. 5 No. 4 FDA, Wyeth, and Global Harmonization
Vol. 5 No. 3 Educate Your Patients about “Unapproved Drugs"
Vol. 5 No. 2 Déjà vu all over again!
Vol. 5 No. 1 A New Year with Opportunities and Challenges
Vol. 4 No. 51 Who do you want to be today? Makeovers!
Vol. 4 No. 50 Avastin: Packaging, Repackaging, or Prepackaging?
Vol. 4 No. 49 Musings on the Length of Pharmacy Education
Vol. 4 No. 48 Revised USP Chapter <797>...Now Available!
Vol. 4 No. 47 Am I Missing Something Here!
Vol. 4 No. 46 Avastin, Genentech, and Particulate Matter
Vol. 4 No. 45 Politics and Truth: An Emulsion or Solution?
Vol. 4 No. 44 Avastin Update
Vol. 4 No. 43 12th Spanish Congress of Compounding Pharmacy
Vol. 4 No. 42 Incredible!!!!
Vol. 4 No. 41 HEADLINE: Prescription Drugs Unavailable!
Vol. 4 No. 40 IJPC-What it is!
Vol. 4 No. 39 Health Insurance: Who should pay?
Vol. 4 No. 38 Discrimination Towards Patients by Insurance Companies!
Vol. 4 No. 37 Professional Terminology
Vol. 4 No. 36 Truth vs Opinion
Vol. 4 No. 35 Truth, Justice, and the American Way!
Vol. 4 No. 34 Decimal Points and Units
Vol. 4 No. 33 Free Prescriptions-What's Wrong with this Picture?
Vol. 4 No. 32 Looking At or Looking Up To!
Vol. 4 No. 31 Adverse Event Reporting in Compounding
Vol. 4 No. 30 Two Good Questions
Vol. 4 No. 29 Multi-State Annual Pharmacy Association Meetings
Vol. 4 No. 28 Best Ever IACP Compounders on Capitol Hill!
Vol. 4 No. 27 The White Coats are Coming!
Vol. 4 No. 26 Freedom!
Vol. 4 No. 25 Off-Label Uses of Drugs
Vol. 4 No. 24 Quality Assurance in Compounding, Part XII
Vol. 4 No. 23 Quality Assurance in Compounding, Part XI
Vol. 4 No. 22 Quality Assurance in Compounding, Part X
Vol. 4 No. 21 Quality Assurance in Compounding, Part IX
Vol. 4 No. 20 Quality Assurance in Compounding, Part VIII
Vol. 4 No. 19 Quality Assurance in Compounding, Part VII
Vol. 4 No. 18 Pharmaceuticals and the Internet
Vol. 4 No. 17 Quality Assurance in Compounding, Part VI
Vol. 4 No. 16 Quality Assurance in Compounding, Part V
Vol. 4 No. 15 Quality Assurance in Compounding, Part IV
Vol. 4 No. 14 Quality Assurance in Compounding, Part III
Vol. 4 No. 13 The Shell Game
Vol. 4 No. 12 Quality Assurance in Compounding, Part II
Vol. 4 No. 11 Quality Assurance in Compounding, Part I
Vol. 4 No. 10 Who's the Criminal?
Vol. 4 No. 9 Sphere of Influence
Vol. 4 No. 8 The International Journal of Pharmaceutical Compounding—More Than a Journal
Vol. 4 No. 7 FDA is Generating Income and Patients Lose Again
Vol. 4 No. 6 How do I Select a Good Compounding Pharmacy?
Vol. 4 No. 5 It Just Doesn't Calculate!
Vol. 4 No. 4 I Don't Really Care About Apathy.
Vol. 4 No. 3 Misrepresentations!
Vol. 4 No. 2 Here We Go Again!
Vol. 4 No. 1 Overs!
Vol. 3 No. 52 Change!
Vol. 3 No. 51 Pharmacy Compounding Accreditation Board Surveyors Trained
Vol. 3 No. 50 The FDA vs the Federal Government
Vol. 3 No. 49 Standard Operating Procedures, Part 2
Vol. 3 No. 48 Standard Operating Procedures, Part 1
Vol. 3 No. 47 The World's Largest College of Pharmacy
Vol. 3 No. 46 Comments on the AMA Resolution
Vol. 3 No. 45 Third-Party Payers Arbitrarily Discriminate
Vol. 3 No. 44 Exhibit Halls at Meetings Reflect Changes
Vol. 3 No. 43 Election time again!
Vol. 3 No. 42 National Community Pharmacy Association (NCPA), Las Vegas, and Compounding
Vol. 3 No. 41 Flak Jacket Not Required
Vol. 3 No. 40 The Problem! Politicians and/or Bureaucrats?
Vol. 3 No. 39 Quality Cannot be Tested into a Preparation, but, How Much is Enough?
Vol. 3 No. 38 Compounding with Commercial Drugs Can Cause Errors!
Vol. 3 No. 37 Big PHARMA and Misinformation!
Vol. 3 No. 36 Why isn't everyone responsible?
Vol. 3 No. 35 Federation of International Pharmacists (FIP) and the International Society of Pharmacy Compounding (ISPhC) Meetings in Brazil
Vol. 3 No. 34 Drugmakers: Optimized for Failure?
Vol. 3 No. 33 Second Pharmaceutical Compounding Quality Assurance Seminar
Vol. 3 No. 32 Whatever Happened to Competition?
Vol. 3 No. 31 Brand-Name Drug Companies Pay to Keep Generics Off the Market
Vol. 3 No. 30 I Can't Believe It! Shake Well!
Vol. 3 No. 29 Majority Suffers Because of the Minority!
Vol. 3 No. 28 Personalized Medicine - Today!
Vol. 3 No. 27 Support your pharmacy organizations!
Vol. 3 No. 26 Headlines! Headlines! Headlines!
Vol. 3 No. 25 Wyeth's FDA Warning letter of May 8, 2006; Part II
Vol. 3 No. 24 Wyeth's FDA Warning letter of May 8, 2006; Part I
Vol. 3 No. 23 AMA Resolution on Non-FDA-Approved Compounded Medications
Vol. 3 No. 22 Pharmacy Compounding in Barcelona
Vol. 3 No. 21 The Wyeth Petition, Part III: Are Today's Conjugated Estrogens "New Drugs"?
Vol. 3 No. 20 Incomplete Labeling for Tacrolimus: Who is to Blame?
Vol. 3 No. 19 The Wyeth Petition, Part II: It's Irrational!
Vol. 3 No. 18 The Wyeth Petition, Part I: Is it Profits or Patients?
Vol. 3 No. 17 Syringes must be used with care!
Vol. 3 No. 16 Learning vs Education
Vol. 3 No. 15 Kudos to the State of Mississippi
Vol. 3 No. 14 First Pharmaceutical Compounding Quality Assurance Seminar
Vol. 3 No. 13 Pharmacy Practice in France: Will it happen here in the US?
Vol. 3 No. 12 European Association of Hospital Pharmacists in Geneva, Switzerland
Vol. 3 No. 11 New Technology and Quality Control: Something New is Coming to Town
Vol. 3 No. 10 I Don't Understand Why...
Vol. 3 No. 9 Pharmacy Organizations: Do they Support You or Themselves?
Vol. 3 No. 8 Patient Care Conflicts With Regulations, Laws, and Standards; AND Why do Insurance Companies Discriminate?
Vol. 3 No. 7 Keep your paper copies!
Vol. 3 No. 6 Kudos to IACP and the New Labeling Guidelines
Vol. 3 No. 5 Corporate Greed!
Vol. 3 No. 4 Talking to a Machine!
Vol. 3 No. 3 "Specials" are not "Sale" Items in UK Pharmacies, Part II
Vol. 3 No. 2 “Specials” are not “Sale” Items in UK Pharmacies, Part 1
Vol. 3 No. 1 Where are the "statesmen"?
Vol. 2 No. 50 Happy New Year
Vol. 2 No. 49 Merry Christmas!
Vol. 2 No. 48 Another Great Idea Gone Bad
Vol. 2 No. 47 FDA and HHS National Leaders Support Individualized Medications!
Vol. 2 No. 46 Orphan Drugs: Part II
Vol. 2 No. 45 Orphan Drugs: Part I
Vol. 2 No. 44 Acacia is Not Just Used in Drugs
Vol. 2 No. 43 Unapproved Drugs, What's the big deal?
Vol. 2 No. 42 Commercially Manufactured Bioidentical Hormones
Vol. 2 No. 41 Chasing Rainbows? Part II
Vol. 2 No. 40 Chasing Rainbows? Part I
Vol. 2 No. 39 How do you keep up with pharmacy information?
Vol. 2 No. 38 Overdosing the American Public? Compounding to the Rescue!
Vol. 2 No. 37 Afraid to take responsibility?
Vol. 2 No. 36 The FDA, Parenteral Drug Association (PDA) and Compounding for Clinical Studies
Vol. 2 No. 35 Is "pharmacy" still a science-based profession?
Vol. 2 No. 34 Kudos to the IJPC CNL and its' Moderator
Vol. 2 No. 33 Priorities: First Three, Then Me!
Vol. 2 No. 32 ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part III
Vol. 2 No. 31 ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part II
Vol. 2 No. 30 ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part I
Vol. 2 No. 29 The Seven Categories of Compounding
Vol. 2 No. 28 The Impending Health Care System Crisis and Pharmaceuticals
Vol. 2 No. 27 Beyond-Use Dates
Vol. 2 No. 26 First Meeting of the USP Compounding Committees in the 2005-2010 Cycle
Vol. 2 No. 25 Contemporary Topics in Pharmaceutical Compounding
Vol. 2 No. 24 Freedom Celebration (including the freedom to compound)
Vol. 2 No. 23 To Split or Not to Split-That is the Question: and the Answer is NO!!!!
Vol. 2 No. 22 The New USP-Pharmacists' Pharmacopeia
Vol. 2 No. 21 IACP-Compounders on Capitol Hill Meeting
Vol. 2 No. 20 Should Pharmacists Handle Dangerous Chemicals
Vol. 2 No. 19 USP-Part 6: General Questions and Comments
Vol. 2 No. 18 USP-Part 5: Resolutions of the 2005 USP Convention, Concluded
Vol. 2 No. 17 USP-Part 4: Resolutions of the 2005 USP Convention, Continued
Vol. 2 No. 16 USP-Part 3: Resolutions of the 2005 USP Convention
Vol. 2 No. 15 USP-Part 2: USP Expert Committee Procedures
Vol. 2 No. 14 USP-Part 1: USP Compounding Pharmacy Expert Committees 2005-2010
Vol. 2 No. 13 Four White Papers
Vol. 2 No. 12 Find Out What You Don't Know
Vol. 2 No. 11 The USP and its Support of Pharmaceutical Compounding
Vol. 2 No. 10 Compounding “Unapproved New Drugs”
Vol. 2 No. 9 Compounding For Office Use-Some Observations and Comments
Vol. 2 No. 8 Affectors of Laboratory Results: Part VIII
Vol. 2 No. 7 Affectors of Laboratory Results: Part VII
Vol. 2 No. 6 Affectors of Laboratory Results: Part VI
Vol. 2 No. 5 Affectors of Laboratory Results: Part V
Vol. 2 No. 4 Affectors of Laboratory Results: Part IV
Vol. 2 No. 3 Affectors of Laboratory Results: Part III
Vol. 2 No. 2 Affectors of Laboratory Results: Part II
Vol. 2 No. 1 Affectors of Laboratory Results: Part I
Vol. 1 No. 6 The Science and Technology of Pharmaceutical Compounding...Worldwide (ISPhC)
Vol. 1 No. 5 Systemic Anti-Inflammatories and Cardiac Problems
Vol. 1 No. 4.1 Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding - Sterile Preparations
Vol. 1 No. 4 What a year for IJPC and compounding!
Vol. 1 No. 3 Therapeutic Blood Levels
Vol. 1 No. 2 USP-NF Grade Ingredients
Vol. 1 No. 1 Introducing CompoundingToday.com